Press Release: Macon Hardy rejoins Unissant as SVP, Business Development

Macon Hardy has rejoined Team Unissant as Senior Vice President, Business Development, focusing on developing and maturing the core capabilities and market relationships of the firm’s work within the Defense Health Agency (DHA) and Veterans Affairs (VA).

“We’re very excited to have Macon back,” says Unissant President Kenneth Bonner. “As a former member of the team, she’s very familiar with the company and our culture. She’ll be able to hit the ground running.”

Prior to joining Unissant, Ms. Hardy held executive positions at both small and large businesses leading the successful capture, management, expansion, and retention of defense and civilian healthcare programs in the federal government market. She stood up the defense and civilian healthcare accounts at Cherokee Nation Businesses and grew the accounts from infancy to maturity to include engagements at component level DoD organizations, joint healthcare organizations to include the MHS and DHA, and HHS. Additionally, she maintained P&L responsibility for a collection of programs critical to the maturation of capabilities to include experience with interagency case management, patient safety, biosurety, and international clinical support.

About Unissant Inc.

Unissant is a data-driven & cyber security services provider with expertise in healthcare and health IT, national security, finance, and energy. Founded in 2006, Unissant is a prime contractor on various government vehicles such as CIO-SP3, GSA PSS, GSA HealthIT SIN, and GSA 8(a) STARS II and is a CMMI Level 3, ISO 9001 & 27001 certified company headquartered in Herndon, Virginia with a satellite office in San Antonio, Texas. Unissant is the recipient of various industry awards such as “Government Project of the Year,” “Health IT Innovation Award” and most recently the “Disruptive Technology in Government” award.

Source: Macon Hardy rejoins Unissant as SVP, Business Development – March 15, 2021. Unissant.

Advertisements

LEAVE A REPLY

Please enter your comment!
Please enter your name here